BioStorage Technologies is expanding its European operations with the opening of a new 16,140 square foot (1,499 sq meters) full-service biorepository in Frankfurt, Germany.
BioStorage’s expanded European operations is part of the company’s strategic growth plan to accommodate a growing list of customers based in Europe. The new facility will offer worldwide, industry-compliant logistics, supply chain management and will meet all international customs and transportation regulations as well as documentation requirements. The company is expected to begin offering services effective immediately.
The expansion comes on the heels of BioStorage Technologies’ announcement that it will create 125 new jobs in the US by expanding its global headquarters in Indianapolis, to include an additional 40,000 square foot cold-storage facility.
John Mills, chief executive officer and chairman of the board at BioStorage, said: “We are pleased to see such rapid global growth since opening our initial Germany-based facility in 2007. Frankfurt has been an ideal location for us to create additional alliances and partnerships with companies conducting pharmaceutical research and development in Europe.”
Wolfgang Hoffer, managing director of BioStorage’s European operations, said: “The extension of our services in Europe will reinforce the scope and depth of significant biomedical and pharmaceutical research conducted by our clients in this part of the world.”
BioStorage’s biorepository would continue to serve pharmaceutical and biotech firms, donor organizations and banks as well as research and academic organizations based in Europe.